메뉴 건너뛰기




Volumn 18, Issue , 2015, Pages 163-169

Specific Lipoprotein(a) apheresis attenuates progression of carotid intima-media thickness in coronary heart disease patients with high lipoprotein(a) levels

Author keywords

Atherosclerosis; Carotid intima media thickness; Immunoadsorption; Lipoprotein(a); Lp(a) apheresis; Regression

Indexed keywords

APOLIPOPROTEIN A2; ATORVASTATIN; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN CHOLESTEROL; BIOLOGICAL MARKER; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

EID: 84928893037     PISSN: 15675688     EISSN: 18785050     Source Type: Journal    
DOI: 10.1016/j.atherosclerosissup.2015.02.025     Document Type: Article
Times cited : (30)

References (28)
  • 1
    • 78649888517 scopus 로고    scopus 로고
    • European Atherosclerosis Society Consensus Panel. Lipoprotein(a) as a cardiovascular risk factor: current status
    • Nordestgaard B.G., Chapman M.J., Ray K., Borén J., Andreotti F., Watts G.F., et al. European Atherosclerosis Society Consensus Panel. Lipoprotein(a) as a cardiovascular risk factor: current status. Eur Heart J 2010, 31:2844-2853.
    • (2010) Eur Heart J , vol.31 , pp. 2844-2853
    • Nordestgaard, B.G.1    Chapman, M.J.2    Ray, K.3    Borén, J.4    Andreotti, F.5    Watts, G.F.6
  • 2
    • 33746208054 scopus 로고    scopus 로고
    • Relation Between Lipoprotein(a) and Fibrinogen and Serial Intravascular Ultrasound Plaque Progression in Left Main Coronary Arteries
    • Hartmann M., von Birgelen C., Mintz G., Stoel M.G., Eggebrecht H., Wieneke H., et al. Relation Between Lipoprotein(a) and Fibrinogen and Serial Intravascular Ultrasound Plaque Progression in Left Main Coronary Arteries. J Am Coll Cardiol 2006, 48:446-452.
    • (2006) J Am Coll Cardiol , vol.48 , pp. 446-452
    • Hartmann, M.1    von Birgelen, C.2    Mintz, G.3    Stoel, M.G.4    Eggebrecht, H.5    Wieneke, H.6
  • 3
    • 67049167090 scopus 로고    scopus 로고
    • Genetically elevated lipoprotein(a) and increased risk of myocardial infarction
    • Kamstrup P.R., Tybjaerg-Hansen A., Steffensen R., Nordestgaard B.G. Genetically elevated lipoprotein(a) and increased risk of myocardial infarction. JAMA 2009, 301:2331-2339.
    • (2009) JAMA , vol.301 , pp. 2331-2339
    • Kamstrup, P.R.1    Tybjaerg-Hansen, A.2    Steffensen, R.3    Nordestgaard, B.G.4
  • 4
    • 67651210632 scopus 로고    scopus 로고
    • Emerging Risk Factors Collaboration. Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality
    • Emerging Risk Factors Collaboration
    • Erqou S., Kaptoge S., Perry P.L., Di Angelantonio E., Thompson A., White I.R., et al. Emerging Risk Factors Collaboration. Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality. JAMA 2009, 302:412-423. Emerging Risk Factors Collaboration.
    • (2009) JAMA , vol.302 , pp. 412-423
    • Erqou, S.1    Kaptoge, S.2    Perry, P.L.3    Di Angelantonio, E.4    Thompson, A.5    White, I.R.6
  • 5
    • 0033554451 scopus 로고    scopus 로고
    • Role of lipoprotein(a) and apolipoprotein(a) phenotype in atherogenesis: prospective results from the Bruneck study
    • Kronenberg F., Kronenberg M.F., Kiechl S., Trenkwalder E., Santer P., Oberhollenzer F., et al. Role of lipoprotein(a) and apolipoprotein(a) phenotype in atherogenesis: prospective results from the Bruneck study. Circulation 1999, 100:1154-1160.
    • (1999) Circulation , vol.100 , pp. 1154-1160
    • Kronenberg, F.1    Kronenberg, M.F.2    Kiechl, S.3    Trenkwalder, E.4    Santer, P.5    Oberhollenzer, F.6
  • 6
    • 33845465759 scopus 로고    scopus 로고
    • Elevated Lipoprotein(a) does not promote early atherosclerotic changes of the carotid arteries in young, healthy adults
    • Grebe M.T., Schoene E., Schaefer C.A., Boedeker R.H., Kemkes-Matthes B., Voss R., et al. Elevated Lipoprotein(a) does not promote early atherosclerotic changes of the carotid arteries in young, healthy adults. Atherosclerosis 2007, 190:194-198.
    • (2007) Atherosclerosis , vol.190 , pp. 194-198
    • Grebe, M.T.1    Schoene, E.2    Schaefer, C.A.3    Boedeker, R.H.4    Kemkes-Matthes, B.5    Voss, R.6
  • 7
    • 84886948388 scopus 로고    scopus 로고
    • Carotid intima-media thickness in asymptomatic subjects with low lipoprotein(a) levels
    • Kotani K., Sakane N. Carotid intima-media thickness in asymptomatic subjects with low lipoprotein(a) levels. J Clin Med Res. 2012, 4:130-134.
    • (2012) J Clin Med Res. , vol.4 , pp. 130-134
    • Kotani, K.1    Sakane, N.2
  • 8
    • 61549101898 scopus 로고    scopus 로고
    • Longitudinal cohort study on the effectiveness of lipid apheresis treatment to reduce high lipoprotein (a) levels and prevent major adverse coronary events
    • Group of Clinical Investigators
    • Jaeger B.R., Richter Y., Nagel D. Longitudinal cohort study on the effectiveness of lipid apheresis treatment to reduce high lipoprotein (a) levels and prevent major adverse coronary events. Nat. Clin. Pract. Cardiovasc. Med 2009, 6:229-239. Group of Clinical Investigators.
    • (2009) Nat. Clin. Pract. Cardiovasc. Med , vol.6 , pp. 229-239
    • Jaeger, B.R.1    Richter, Y.2    Nagel, D.3
  • 9
    • 84890904215 scopus 로고    scopus 로고
    • Lipoprotein apheresis in patients with maximally tolerated lipid-lowering therapy, lipoprotein(a)-hyperlipoproteinemia, and progressive cardiovascular disease: prospective observational multicenter study
    • Pro(a)LiFe Study Group
    • Leebmann J., Roeseler E., Julius U., Heigl F., Spitthoever R., Heutling D., et al. Lipoprotein apheresis in patients with maximally tolerated lipid-lowering therapy, lipoprotein(a)-hyperlipoproteinemia, and progressive cardiovascular disease: prospective observational multicenter study. Circulation 2013, 128:2567-2576. Pro(a)LiFe Study Group.
    • (2013) Circulation , vol.128 , pp. 2567-2576
    • Leebmann, J.1    Roeseler, E.2    Julius, U.3    Heigl, F.4    Spitthoever, R.5    Heutling, D.6
  • 10
    • 84872876060 scopus 로고    scopus 로고
    • Effect of specific lipoprotein(a) apheresis on coronary atherosclerosis regression assessed by quantitative coronary angiography
    • Safarova M.S., Ezhov M.V., Afanasieva O.I., Matchin Y.G., Atanesyan R.V., Adamova I.Y., et al. Effect of specific lipoprotein(a) apheresis on coronary atherosclerosis regression assessed by quantitative coronary angiography. Atheroscler Suppl. 2013, 14(1):93-99.
    • (2013) Atheroscler Suppl. , vol.14 , Issue.1 , pp. 93-99
    • Safarova, M.S.1    Ezhov, M.V.2    Afanasieva, O.I.3    Matchin, Y.G.4    Atanesyan, R.V.5    Adamova, I.Y.6
  • 11
    • 0016998022 scopus 로고
    • Grading of angina pectoris (Letter to the Editor)
    • Campeau L. Grading of angina pectoris (Letter to the Editor). Circulation 1976, 54:522-523.
    • (1976) Circulation , vol.54 , pp. 522-523
    • Campeau, L.1
  • 12
    • 38849140265 scopus 로고    scopus 로고
    • Use of carotid ultrasound to identify subclinical vascular disease and evaluate cardiovascular disease risk: a consensus statement from the American Society of Echocardiography Carotid Intima-Media Thickness Task Force. Endorsed by the Society for Vascular Medicine
    • American Society of Echocardiography Carotid Intima-Media Thickness Task Force
    • Stein J.H., Korcarz C.E., Hurst R.T., Lonn E., Kendall C.B., Mohler E.R., et al. Use of carotid ultrasound to identify subclinical vascular disease and evaluate cardiovascular disease risk: a consensus statement from the American Society of Echocardiography Carotid Intima-Media Thickness Task Force. Endorsed by the Society for Vascular Medicine. J Am Soc Echocardiogr 2008, 21:93-111. American Society of Echocardiography Carotid Intima-Media Thickness Task Force.
    • (2008) J Am Soc Echocardiogr , vol.21 , pp. 93-111
    • Stein, J.H.1    Korcarz, C.E.2    Hurst, R.T.3    Lonn, E.4    Kendall, C.B.5    Mohler, E.R.6
  • 13
    • 84868239835 scopus 로고    scopus 로고
    • Mannheim carotid intima-media thickness and plaque consensus (2004-2006-2011). An update on behalf of the advisory board of the 3rd, 4th and 5th watching the risk symposia, at the 13th, 15th and 20th European Stroke Conferences, Mannheim, Germany, 2004, Brussels, Belgium, 2006, and Hamburg, Germany, 2011
    • Touboul P.J., Hennerici M.G., Meairs S., Adams H., Amarenco P., Bornstein N., et al. Mannheim carotid intima-media thickness and plaque consensus (2004-2006-2011). An update on behalf of the advisory board of the 3rd, 4th and 5th watching the risk symposia, at the 13th, 15th and 20th European Stroke Conferences, Mannheim, Germany, 2004, Brussels, Belgium, 2006, and Hamburg, Germany, 2011. Cerebrovasc Dis 2012, 34:290-296.
    • (2012) Cerebrovasc Dis , vol.34 , pp. 290-296
    • Touboul, P.J.1    Hennerici, M.G.2    Meairs, S.3    Adams, H.4    Amarenco, P.5    Bornstein, N.6
  • 14
    • 33947713026 scopus 로고    scopus 로고
    • Effect of rosuvastatin on progression of carotid intima-media thickness in low-risk individuals with subclinical atherosclerosis: the METEOR Trial
    • Crouse J.R., Raichlen J.S., Riley W.A., Evans G.W., Palmer M.K., O'Leary D.H., et al. Effect of rosuvastatin on progression of carotid intima-media thickness in low-risk individuals with subclinical atherosclerosis: the METEOR Trial. JAMA 2007, 297:1344-1353.
    • (2007) JAMA , vol.297 , pp. 1344-1353
    • Crouse, J.R.1    Raichlen, J.S.2    Riley, W.A.3    Evans, G.W.4    Palmer, M.K.5    O'Leary, D.H.6
  • 15
    • 84921509674 scopus 로고    scopus 로고
    • Lipoprotein(a) level and apolipoprotein(a) phenotype as predictors of long-term cardiovascular outcomes after coronary artery bypass grafting
    • Ezhov M.V., Safarova M.S., Afanasieva O.I., Kukharchuk V.V., Pokrovsky S.N. Lipoprotein(a) level and apolipoprotein(a) phenotype as predictors of long-term cardiovascular outcomes after coronary artery bypass grafting. Atherosclerosis 2014, 235:477-482.
    • (2014) Atherosclerosis , vol.235 , pp. 477-482
    • Ezhov, M.V.1    Safarova, M.S.2    Afanasieva, O.I.3    Kukharchuk, V.V.4    Pokrovsky, S.N.5
  • 16
    • 0033811877 scopus 로고    scopus 로고
    • The rebound of lipoproteins after LDL-apheresis. Kinetics and estimation of mean lipoprotein levels
    • Kroon A.A., van't Hof M.A., Demacker P.N., Stalenhoef A.F. The rebound of lipoproteins after LDL-apheresis. Kinetics and estimation of mean lipoprotein levels. Atherosclerosis 2000, 152:519-526.
    • (2000) Atherosclerosis , vol.152 , pp. 519-526
    • Kroon, A.A.1    van't Hof, M.A.2    Demacker, P.N.3    Stalenhoef, A.F.4
  • 17
    • 84881381644 scopus 로고    scopus 로고
    • Guidelines on the use of therapeutic apheresis in clinical practice-evidence-based approach from the Writing Committee of the American Society for Apheresis: the sixth special issue
    • Schwartz J., Winters J.L., Padmanabhan A., Balogun R.A., Delaney M., Linenberger M.L., et al. Guidelines on the use of therapeutic apheresis in clinical practice-evidence-based approach from the Writing Committee of the American Society for Apheresis: the sixth special issue. J Clin Apher 2013, 28:145-284.
    • (2013) J Clin Apher , vol.28 , pp. 145-284
    • Schwartz, J.1    Winters, J.L.2    Padmanabhan, A.3    Balogun, R.A.4    Delaney, M.5    Linenberger, M.L.6
  • 19
    • 0029994827 scopus 로고    scopus 로고
    • Low-density lipoprotein apheresis in the treatment of two patients with coronary heart disease and extremely elevated lipoprotein(a) levels
    • Bambauer R., Schiel R., Keller H.E., Klinkmann J., Latza R. Low-density lipoprotein apheresis in the treatment of two patients with coronary heart disease and extremely elevated lipoprotein(a) levels. Artif Organs 1996, 20:340-343.
    • (1996) Artif Organs , vol.20 , pp. 340-343
    • Bambauer, R.1    Schiel, R.2    Keller, H.E.3    Klinkmann, J.4    Latza, R.5
  • 20
    • 0347874855 scopus 로고    scopus 로고
    • Lipoprotein(a)-apheresis in the secondary prevention of coronary heart disease
    • Ullrich H., Lackner K., Schmitz G. Lipoprotein(a)-apheresis in the secondary prevention of coronary heart disease. Transfus Sci. 1996, 17:511-517.
    • (1996) Transfus Sci. , vol.17 , pp. 511-517
    • Ullrich, H.1    Lackner, K.2    Schmitz, G.3
  • 22
    • 0034159755 scopus 로고    scopus 로고
    • Carotid wall thickness is predictive of incident clinical stroke: the Atherosclerosis Risk in Communities (ARIC) study
    • Chambless L.E., Folsom A., Clegg L.X., Sharrett A.R., Shahar E., Nieto F.J., et al. Carotid wall thickness is predictive of incident clinical stroke: the Atherosclerosis Risk in Communities (ARIC) study. Am J Epidemiol 2000, 151:478-487.
    • (2000) Am J Epidemiol , vol.151 , pp. 478-487
    • Chambless, L.E.1    Folsom, A.2    Clegg, L.X.3    Sharrett, A.R.4    Shahar, E.5    Nieto, F.J.6
  • 23
    • 0035941786 scopus 로고    scopus 로고
    • Effect of aggressive versus conventional lipid lowering on atherosclerosis progression in familial hypercholesterolaemia (ASAP): a prospective, randomised, double-blind trial
    • Smilde T.J., van Wissen S., Wollersheim H., Trip M.D., Kastelein J.J., Stalenhoef A.F. Effect of aggressive versus conventional lipid lowering on atherosclerosis progression in familial hypercholesterolaemia (ASAP): a prospective, randomised, double-blind trial. Lancet 2001, 357:577-581.
    • (2001) Lancet , vol.357 , pp. 577-581
    • Smilde, T.J.1    van Wissen, S.2    Wollersheim, H.3    Trip, M.D.4    Kastelein, J.J.5    Stalenhoef, A.F.6
  • 24
    • 33846609195 scopus 로고    scopus 로고
    • Prediction of clinical cardiovascular events with carotid intima-media thickness: a systematic review and meta-analysis
    • Lorenz M.W., Markus H.S., Bots M.L., Rosvall M., Sitzer M. Prediction of clinical cardiovascular events with carotid intima-media thickness: a systematic review and meta-analysis. Circulation 2007, 115:459-467.
    • (2007) Circulation , vol.115 , pp. 459-467
    • Lorenz, M.W.1    Markus, H.S.2    Bots, M.L.3    Rosvall, M.4    Sitzer, M.5
  • 25
    • 0029882936 scopus 로고    scopus 로고
    • LDL-Apheresis Atherosclerosis Regression Study (LAARS). Effect of aggressive versus conventional lipid lowering treatment on coronary atherosclerosis
    • Kroon A.A., Aengevaeren W.R., van der Werf T., Uijen G.J., Reiber J.H., Bruschke A.V., Stalenhoef A.F. LDL-Apheresis Atherosclerosis Regression Study (LAARS). Effect of aggressive versus conventional lipid lowering treatment on coronary atherosclerosis. Circulation 1996, 93:1826-1835.
    • (1996) Circulation , vol.93 , pp. 1826-1835
    • Kroon, A.A.1    Aengevaeren, W.R.2    van der Werf, T.3    Uijen, G.J.4    Reiber, J.H.5    Bruschke, A.V.6    Stalenhoef, A.F.7
  • 26
    • 0029096765 scopus 로고
    • Kuopio Atherosclerosis Prevention Study (KAPS). A population-based primary preventive trial of the effect of LDL lowering on atherosclerotic progression in carotid and femoral arteries
    • Salonen R., Nyyssönen K., Porkkala E., Rummukainen J., Belder R., Park J.S., Salonen J.T. Kuopio Atherosclerosis Prevention Study (KAPS). A population-based primary preventive trial of the effect of LDL lowering on atherosclerotic progression in carotid and femoral arteries. Circulation 1995, 92:1758-1764.
    • (1995) Circulation , vol.92 , pp. 1758-1764
    • Salonen, R.1    Nyyssönen, K.2    Porkkala, E.3    Rummukainen, J.4    Belder, R.5    Park, J.S.6    Salonen, J.T.7
  • 27
    • 80052384849 scopus 로고    scopus 로고
    • [Pleiotropic effects of nicotinic acid therapy in men with coronary heart disease and elevated lipoprotein(a) levels]
    • [Russian]
    • Safarova M.S., Trukhacheva E.P., Ezhov M.V., Afanas'eva O.I., Afanas'eva M.I., Tripoten' M.I., et al. [Pleiotropic effects of nicotinic acid therapy in men with coronary heart disease and elevated lipoprotein(a) levels]. Kardiologiia 2011, 51(5):9-16. [Russian].
    • (2011) Kardiologiia , vol.51 , Issue.5 , pp. 9-16
    • Safarova, M.S.1    Trukhacheva, E.P.2    Ezhov, M.V.3    Afanas'eva, O.I.4    Afanas'eva, M.I.5    Tripoten', M.I.6
  • 28
    • 79960205374 scopus 로고    scopus 로고
    • European Society of Cardiology (ESC); European Atherosclerosis Society (EAS). ESC/EAS Guidelines for the management of dyslipidaemias The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)
    • Catapano A.L., Reiner Z., De Backer G., Graham I., Taskinen M.R., Wiklund O., et al. European Society of Cardiology (ESC); European Atherosclerosis Society (EAS). ESC/EAS Guidelines for the management of dyslipidaemias The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). Atherosclerosis 2011, 217:3-46.
    • (2011) Atherosclerosis , vol.217 , pp. 3-46
    • Catapano, A.L.1    Reiner, Z.2    De Backer, G.3    Graham, I.4    Taskinen, M.R.5    Wiklund, O.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.